{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:32:53Z","timestamp":1768559573045,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"DOI":"10.7759\/cureus.47742","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T17:52:52Z","timestamp":1698342772000},"source":"Crossref","is-referenced-by-count":5,"title":["Discontinuation of Levetiracetam and Valproic Acid Due to Adverse Effects in Early Post-traumatic Seizure Prophylaxis"],"prefix":"10.7759","author":[{"given":"Sami M","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ziechmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Menzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ava","family":"Hoeft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02689-1","article-title":"Traumatic brain injury","volume":"356","author":"Ghajar J","year":"2000","unstructured":"Ghajar J. Traumatic brain injury. Lancet. 2000, 356:923-9. 10.1016\/S0140-6736(00)02689-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/026990596124719","article-title":"Incidence of mild and moderate brain injury in the United States, 1991","volume":"10","author":"Sosin DM","year":"1996","unstructured":"Sosin DM, Sniezek JE, Thurman DJ. Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj. 1996, 10:47-54. 10.1080\/026990596124719","journal-title":"Brain Inj"},{"key":"ref3","article-title":"Post-traumatic seizures and epilepsy","author":"Yablon SA","year":"2007","unstructured":"Yablon SA, Dostrow VG. Post-traumatic seizures and epilepsy. Brain Injury Medicine: Principles and Practice. Zasler ND, Katz DI, Zafonte RD (ed): Demos Medical Publishing, New York, NY; 2007. 443-68."},{"key":"ref4","article-title":"Posttraumatic seizures","volume":"74","author":"Yablon SA","year":"1993","unstructured":"Yablon SA. Posttraumatic seizures. Arch Phys Med Rehabil. 1993, 74:983-1001.","journal-title":"Arch Phys Med Rehabil"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09926-w","article-title":"A review of seizures and epilepsy following traumatic brain injury","volume":"267","author":"Fordington S","year":"2020","unstructured":"Fordington S, Manford M. A review of seizures and epilepsy following traumatic brain injury. J Neurol. 2020, 267:3105-11. 10.1007\/s00415-020-09926-w","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-016-0363-6","article-title":"Prevalence and risk factors for early seizure in patients with traumatic brain injury: analysis from National Trauma Data Bank","volume":"27","author":"Majidi S","year":"2017","unstructured":"Majidi S, Makke Y, Ewida A, Sianati B, Qureshi AI, Koubeissi MZ. Prevalence and risk factors for early seizure in patients with traumatic brain injury: analysis from National Trauma Data Bank. Neurocrit Care. 2017, 27:90-5. 10.1007\/s12028-016-0363-6","journal-title":"Neurocrit Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.44.s10.4.x","article-title":"Epidemiology of posttraumatic epilepsy: a critical review","volume":"44","author":"Frey LC","year":"2003","unstructured":"Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia. 2003, 44:11-7. 10.1046\/j.1528-1157.44.s10.4.x","journal-title":"Epilepsia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.260201","article-title":"Post-traumatic epilepsy: review of risks, pathophysiology, and potential biomarkers","volume":"26","author":"Lamar CD","year":"2014","unstructured":"Lamar CD, Hurley RA, Rowland JA, Taber KH. Post-traumatic epilepsy: review of risks, pathophysiology, and potential biomarkers. J Neuropsychiatry Clin Neurosci. 2014, 26:iv-113. 10.1176\/appi.neuropsych.260201","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2005.09.001","article-title":"Post-traumatic epilepsy: an overview","volume":"108","author":"Agrawal A","year":"2006","unstructured":"Agrawal A, Timothy J, Pandit L, Manju M. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg. 2006, 108:433-9. 10.1016\/j.clineuro.2005.09.001","journal-title":"Clin Neurol Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008233230801","article-title":"A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures","volume":"323","author":"Temkin NR","year":"1990","unstructured":"Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990, 323:497-502. 10.1056\/NEJM199008233230801","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1979.51.4.0507","article-title":"Prophylactic phenytoin in severe head injuries","volume":"51","author":"Wohns RN","year":"1979","unstructured":"Wohns RN, Wyler AR. Prophylactic phenytoin in severe head injuries. J Neurosurg. 1979, 51:507-9. 10.3171\/jns.1979.51.4.0507","journal-title":"J Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2013.06.002","article-title":"Information\/education page. Seizures and traumatic brain injury","volume":"95","author":"Englander J","year":"2014","unstructured":"Englander J, Cifu DX, Diaz-Arrastia R. Information\/education page. Seizures and traumatic brain injury. Arch Phys Med Rehabil. 2014, 95:1223-4. 10.1016\/j.apmr.2013.06.002","journal-title":"Arch Phys Med Rehabil"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/02699052.2016.1170882","article-title":"The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: a systematic review and meta-analysis","volume":"30","author":"Xu JC","year":"2016","unstructured":"Xu JC, Shen J, Shao WZ, et al.. The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: a systematic review and meta-analysis. Brain Inj. 2016, 30:1054-61. 10.3109\/02699052.2016.1170882","journal-title":"Brain Inj"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/02688697.2018.1464118","article-title":"A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury","volume":"32","author":"Bakr A","year":"2018","unstructured":"Bakr A, Belli A. A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury. Br J Neurosurg. 2018, 32:237-44. 10.1080\/02688697.2018.1464118","journal-title":"Br J Neurosurg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen CU","year":"2003","unstructured":"Johannessen CU, Johannessen SI. Valproate: past, present, and future. CNS Drug Rev. 2003, 9:199-216. 10.1111\/j.1527-3458.2003.tb00249.x","journal-title":"CNS Drug Rev"},{"key":"ref16","article-title":"Valproate oral loading in the treatment of acute mania","volume":"54","author":"Keck PE Jr","year":"1993","unstructured":"Keck PE Jr, McElroy SL, Tugrul KC, Bennett JA. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry. 1993, 54:305-8.","journal-title":"J Clin Psychiatry"},{"key":"ref17","article-title":"Treatment of mania, mixed state, and rapid cycling","volume":"42","author":"Kusumakar V","year":"1997","unstructured":"Kusumakar V, Yatham LN, Haslam DR, Parikh SV, Matte R, Silverstone PH, Sharma V. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry. 1997, 42:79S-86S.","journal-title":"Can J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000118970","article-title":"Valproate as a loading treatment in acute mania","volume":"27","author":"McElroy SL","year":"1993","unstructured":"McElroy SL, Keck PE Jr, Tugrul KC, Bennett JA. Valproate as a loading treatment in acute mania. Neuropsychobiology. 1993, 27:146-9. 10.1159\/000118970","journal-title":"Neuropsychobiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2018.07.012","article-title":"Levetiracetam","volume":"56","author":"Howard P","year":"2018","unstructured":"Howard P, Remi J, Remi C, et al.. Levetiracetam. J Pain Symptom Manage. 2018, 56:645-9. 10.1016\/j.jpainsymman.2018.07.012","journal-title":"J Pain Symptom Manage"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0224-6","article-title":"The risk of thrombocytopenia during valproic acid therapy: a critical summary of available clinical data","volume":"18","author":"Buoli M","year":"2018","unstructured":"Buoli M, Serati M, Botturi A, Altamura AC. The risk of thrombocytopenia during valproic acid therapy: a critical summary of available clinical data. Drugs R D. 2018, 18:1-5. 10.1007\/s40268-017-0224-6","journal-title":"Drugs R D"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1358\/mf.1998.20.4.485692","article-title":"Prophylactic sodium valproate therapy in patients with drug-resistant migraine","volume":"20","author":"Ghose K","year":"1998","unstructured":"Ghose K, Niven B. Prophylactic sodium valproate therapy in patients with drug-resistant migraine. Methods Find Exp Clin Pharmacol. 1998, 20:353-9. 10.1358\/mf.1998.20.4.485692","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.01154-4.x","article-title":"Antiepileptic drugs in migraine prevention","volume":"41","author":"Mathew NT","year":"2001","unstructured":"Mathew NT. Antiepileptic drugs in migraine prevention. Headache. 2001, 41:S18-24. 10.1046\/j.1526-4610.2001.01154-4.x","journal-title":"Headache"},{"key":"ref23","article-title":"Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial","volume":"12","author":"Mitsikostas DD","year":"1997","unstructured":"Mitsikostas DD, Polychronidis I. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial. Funct Neurol. 1997, 12:267-276.","journal-title":"Funct Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13582","article-title":"Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a traumatic brain injury model systems study","volume":"57","author":"Ritter AC","year":"2016","unstructured":"Ritter AC, Wagner AK, Fabio A, et al.. Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a traumatic brain injury model systems study. Epilepsia. 2016, 57:1968-77. 10.1111\/epi.13582","journal-title":"Epilepsia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.5420","article-title":"Risk factors and prognosis of early posttraumatic seizures in moderate to severe traumatic brain injury","volume":"79","author":"Laing J","year":"2022","unstructured":"Laing J, Gabbe B, Chen Z, Perucca P, Kwan P, O'Brien TJ. Risk factors and prognosis of early posttraumatic seizures in moderate to severe traumatic brain injury. JAMA Neurol. 2022, 79:334-41. 10.1001\/jamaneurol.2021.5420","journal-title":"JAMA Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000159249.68363.78","article-title":"Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination","volume":"58","author":"Carrick MM","year":"2005","unstructured":"Carrick MM, Tyroch AH, Youens CA, Handley T. Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination. J Trauma. 2005, 58:725-9. 10.1097\/01.ta.0000159249.68363.78","journal-title":"J Trauma"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02788.x","article-title":"Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study","volume":"51","author":"Sahaya K","year":"2010","unstructured":"Sahaya K, Goyal MK, Sarwal A, Singh NN. Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study. Epilepsia. 2010, 51:2492-5. 10.1111\/j.1528-1167.2010.02788.x","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.6.673","article-title":"Hepatotoxicity to sodium valproate: a review","volume":"25","author":"Powell-Jackson PR","year":"1984","unstructured":"Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut. 1984, 25:673-81. 10.1136\/gut.25.6.673","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1081\/clt-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer MD","year":"2002","unstructured":"Sztajnkrycer MD. Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol. 2002, 40:789-801. 10.1081\/clt-120014645","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000074668","article-title":"Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?","volume":"70","author":"Lackmann GM","year":"2004","unstructured":"Lackmann GM. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?. Pharmacology. 2004, 70:57-8. 10.1159\/000074668","journal-title":"Pharmacology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193898-discontinuation-of-levetiracetam-and-valproic-acid-due-to-adverse-effects-in-early-post-traumatic-seizure-prophylaxis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:07Z","timestamp":1707508507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193898-discontinuation-of-levetiracetam-and-valproic-acid-due-to-adverse-effects-in-early-post-traumatic-seizure-prophylaxis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.47742","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}